FRANCO SONG SEO: Open Payments
NPI 1609027788 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 27 payments from 13 companies in 2025. Trend: 2023 $58 · 2024 $843 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Indivior Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $26 |
| Noven Therapeutics, LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: AUSTEDO XR, CAPLYTA, SPRAVATO, FANAPT, SUBLOCADE, UZEDY, REXULTI, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
